Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-04-18 @ 10:13 PM
Study NCT ID:
NCT01163357
Status:
COMPLETED
Last Update Posted:
2025-03-26
First Post:
2010-07-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
Sponsor:
City of Hope Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
09171
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |